These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10756725)

  • 21. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture.
    Toda S; Nishimura T; Yamada S; Koike N; Yonemitsu N; Watanabe K; Matsumura S; Gärtner R; Sugihara H
    J Pathol; 1999 Aug; 188(4):415-22. PubMed ID: 10440753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells.
    Sato Y; Sonoda H
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):37-41. PubMed ID: 17095714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the biology of angiogenesis: review of the most important molecular mechanisms.
    Otrock ZK; Mahfouz RA; Makarem JA; Shamseddine AI
    Blood Cells Mol Dis; 2007; 39(2):212-20. PubMed ID: 17553709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis: a dynamic balance of stimulators and inhibitors.
    Iruela-Arispe ML; Dvorak HF
    Thromb Haemost; 1997 Jul; 78(1):672-7. PubMed ID: 9198237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis in normal and neoplastic pituitary tissues.
    Lloyd RV; Vidal S; Horvath E; Kovacs K; Scheithauer B
    Microsc Res Tech; 2003 Feb; 60(2):244-50. PubMed ID: 12539179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor and angiogenesis.
    Hoeben A; Landuyt B; Highley MS; Wildiers H; Van Oosterom AT; De Bruijn EA
    Pharmacol Rev; 2004 Dec; 56(4):549-80. PubMed ID: 15602010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis: basic and clinical aspects.
    Ribatti D; Vacca A; Nico B; Presta M; Roncali L
    Ital J Anat Embryol; 2003; 108(1):1-24. PubMed ID: 12737512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.
    Ribatti D
    Br J Haematol; 2005 Feb; 128(3):303-9. PubMed ID: 15667531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
    Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.
    Laschke MW; Elitzsch A; Vollmar B; Vajkoczy P; Menger MD
    Hum Reprod; 2006 Jan; 21(1):262-8. PubMed ID: 16172144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenic and angiostatic factors in the molecular control of angiogenesis.
    Distler JH; Hirth A; Kurowska-Stolarska M; Gay RE; Gay S; Distler O
    Q J Nucl Med; 2003 Sep; 47(3):149-61. PubMed ID: 12897707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The placenta growth factor in skin angiogenesis.
    Odorisio T; Cianfarani F; Failla CM; Zambruno G
    J Dermatol Sci; 2006 Jan; 41(1):11-9. PubMed ID: 16216466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endothelial cell function and angiogenesis].
    Kanayasu-Toyoda T; Morita I; Murota S
    Nihon Yakurigaku Zasshi; 1996 Mar; 107(3):99-107. PubMed ID: 8728283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis in rheumatoid arthritis.
    Maruotti N; Cantatore FP; Crivellato E; Vacca A; Ribatti D
    Histol Histopathol; 2006 May; 21(5):557-66. PubMed ID: 16493585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.